A Proof-of-mechanism Study of Multiple, Oral Doses of Fevipiprant (QAW039) in COPD Patients With Eosinophilia
Clinical trial NCT03810183 · TERMINATED
Trial details
- NCT number
- NCT03810183
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-21
- Primary completion
- 2020-01-16
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.